Glucose-based modulation of electrical stimulation to enable weight loss
US11957895B2 · kind B2 · utility
Inventors
Key dates
| Filing date | Feb 7, 2023 |
| Grant date | Apr 16, 2024 |
| Priority date | — |
| Expiry date | Feb 7, 2043 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61N1/36085
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
The disclosed electrical stimulation system generates interventions to assist patients in complying with a diet. The wearable device includes a microprocessor, electrical stimulator and at least one electrode configured to deliver electrical stimulation to the epidermis, through a range of 0.1 mm to 10 mm or a range of 0.1 mm to 20 mm of the dermis, of a T2 dermatome to a T12 dermatome or meridian of the patient, a C5 to a T1 dermatome across the hand and/or arm, and/or the upper chest regions. The device is adapted to provide electrical stimulation as per stimulation protocols and to communicate wirelessly with a companion control device configured to monitor and record appetite patterns of the patient and deliver titrated therapy. The control device is also configured to monitor, record, and modify stimulation parameters of the stimulation protocols.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.